The 7 percent unemployment rate accompanied a gain of 203,000 jobs
A Needham & Co. report estimates that most cable TV channels would vanish if consumers could—as they say they'd prefer—spend $30 monthly on 15 to 20 channels
Challenges to patents, transparency for demand letters, and litigation fees are crucial
It lets customers go off the grid when utilities charge their highest rates and provides a backup during outages
The settlement ends an eight-year legal fight waged by African American brokers
Jeff Bezos's plan to deliver packages via unmanned aerial drones is crazy—which means you shouldn't bet against him
After selling out 5,000 designer Starbucks cards in six minutes last year, Starbucks is offering a mere 1,000 of them at noon on Friday
Northwestern's Kellogg School of Management reclaims the top stop after a two-year absence
Immigrant entrepreneurs and companies with intellectual property are more likely to hire
Founders: Dr. Samir Patel and Dr. David Guyer
VC Investment over the last four quarters: $37.47 million
Founded in 2007, the 15-employee Ophthotech is a biotech company developing treatments for age-related macular degeneration, a common cause of vision loss in older adults. The co-founders' prior venture, Eyetech, was acquired by OSI Pharmaceuticals (OSIP) in 2005 in a deal valued at $900 million.
Key to startup success: "[Our] in-depth understanding of the specific specialty pharma space, coupled with an experienced management and venture investors, has been key to our success."